# Orapred ODT

NDC: 59212-701
Generic name: prednisolone sodium phosphate
Labeler / Manufacturer: Advanz Pharma (US) Corp.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, ORALLY DISINTEGRATING
Routes: ORAL
Marketing started: 20060601

FDA application: NDA021959

## Active ingredients

- PREDNISOLONE SODIUM PHOSPHATE: 15 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59212-701"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59212-701
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1e379543-c4cf-4e72-953b-db15b7f0c2a1